PharmaTimes June 17, 2024
Cancer was estimated to be responsible for more than 18 million cases worldwide in 2020
Leuko, founded by researchers at the Massachusetts Institute of Technology (MIT), has developed an at-home white blood cell monitor to help doctors non-invasively monitor cancer patients’ health during chemotherapy.
The PointCheck device provides an easy-to-use way of recording immune health for doctors and optimising cancer treatment for patients.
In 2020, it was estimated that cancer was responsible for more than 18 million cases worldwide, according to Cancer Research UK.
Chemotherapy works to destroy cancer cells, which can also destroy patients’ immune cells, leading to tens of thousands of cancer patients with weakened immune systems every year, putting them at risk of contracting infections.
In an...
Today's Sponsors
Today's Sponsor